New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells

Journal of Cellular Biochemistry

Volumn 95, Issue 1, 2005, Pages 45-52

  Sirover, Michael A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer chemotherapy; GAPDH; Glyceraldehyde 3 phosphate dehydrogenase; Membrane fusion; Metabolic syndrome; Post translational modification; Telomere structure; Transcriptional regulation

Indexed keywords

DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOLYTIC ENZYME; NUCLEOTIDE; HISTONE; NUCLEAR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; COMPLEX FORMATION; DRUG EXPOSURE; ENERGY YIELD; ENZYME STRUCTURE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; MAMMAL CELL; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; STRESS; TELOMERE; ANIMAL; BIOSYNTHESIS; CELL CYCLE S PHASE; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; REVIEW;

MAMMALIA;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HISTONES; HUMANS; HYPERGLYCEMIA; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; S PHASE; TELOMERE;

EID: 23844452781     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20399     Document Type: Article

References (57)

1. Abraham WT. 2004. Preventing cardiovascular events in patients with diabetes mellitus. Am J Med 116(Suppl 5A):39S-46S.
2. Alexander-Bridges M, Dugast I, Ercolani L, Kong XF, Giere L, Nasrin N. 1992. Multiple insulin-responsive elements regulate transcription of the GAPDH gene. Advan Enzyme Regul 32:149-159.
3. 2+/calmodulin-dependent protein kinase II. FEBS Lett 231:413-416.
4. Baumann P, Cech TR. 2001. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292:1171-1175.
5. Broccoli D, Smogorzewska A, Chong L, de Lange T. 1997. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet 17:231-235.
6. Brown VM, Krynetski EY, Krynetskaia NF, Grieger D, Mukatira ST, Murti KG, Slaughter CA, Park H-W, Evans WE. 2004. A novel CRM1-mediated nuclear export signal governs nuclear accumulation of glyceraldehydes-3-phosphate dehydrogenase following genotoxic stress. J Biol Chem 279:5984-5992.
7. Caballero AE, Arora S, Saouaf R, et al. 1999. Micro- and macro-vascular reactivity is impaired in subjects at risk for type 2 diabetes. Diabetes 48:1863-1867.
8. Carlile GW, Tatton WG, Borden KLB. 1998. Demonstration of a RNA-dependent nuclear interaction between the promyelocytic protein and glyceraldehyde-3- phosphate dehydrogenase. Biochem J 335:691-696.
9. Chakhparonian M, Wellinger RJ. 2003. Telomere maintenance and DNA replication: How close are they connected? Trends Genet 19:439-446.
10. Corbin Gong Y, Zhang M, Minuk GY. 2002. Proliferative and nutritional dependent regulation of glyceraldehyde-3-phosphate dehydrogenase expression in the rat liver. Cell Prolif 38:173-182.
11. Davie JR, Spencer VA. 1999. Control of histone modifications. J Cell Biochem Suppl 32-33:141-148.
12. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccvaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Levy N. 2003. Lamin A truncation in Hutchinson-Gilford progeria. Science 300:2005.
13. Du X, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M. 2000. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci 97:12222-12226.
14. Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee M. 2003. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112:1049-1057.
15. Eriksson M, Bortwn WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS. 2003. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423:293-298.
16. Fletcher C, Heintz N, Roeder RG. 1987. Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene. Cell 51:773-781.
17. Giardino I, Edelstein D, Brownlee M. 1996. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 97:1422-1428.
18. Glaser PE, Gross RW. 1995. Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3 phosphate dehydrogenase: Discrimination between glycolytic and fusogenic roles of individual isoforms. Biochemistry 34:12194-12203.
19. Glaser PE, Han X, Gross RW. 2002. Tubulin is the endogenous inhibitor of the glyceraldehyde-3-phosphate dehydrogenase isoform that catalyzes membrane fusion: Implications for the coordinated regulation of glycolysis and membrane fusion. Proc Natl Acad Sci USA 99: 14104-14108.
20. Graven KK, Yu Q, Pan D, Roncarati JS, Farber HW. 1999. Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate gene. Biochim Biophys Acta 1447:208-218.
21. Gross ER, LaDisa JF Jr, Weihrauch D, Olson LE, Kress TT, Hettrick DA, Pagel PS, Warltier DC, Kersten JR. 2003. Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia. Amer J Phys 284:H1552-H1559.
22. Hanson RL, Imperatore G, Bennett PH, Knowler WC. 2002. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51:3120-3127.
23. Ishitani R, Chuang D-M. 1996. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside- induced apoptosis in cultured cerebellar neurons. Proc Natl Acad Sci USA 93:9937-9941.
24. Kaneda M, Takeuchi K, Inoue K, Umeda M. 1997. Localization of the phosphatidylserine-binding site of glyceraldehyde-3-phosphate dehydrogenase responsible for membrane fusion. J Biochem 122:1233-1240.
25. Kawamoto RM, Caswell AH. 1986. Autophosphorylation of glyceraldehydephosphate dehydrogenase and phosphorylation of protein from skeletal muscle microsomes. Biochemistry 25:656-661.
26. Khorasanizadeh S. 2004. The nucleosome: From genomic organization to genomic regulation. Cell 116:259-272.
27. Knight RJ, Kofoed KF, Schelbert HR, Buxton DB. 1996. Inhibition of glyceraldehyde-3-phosphate dehydrogenase in post-ischaemic myocardium. Cardiovas Res 32:1016-1023.
28. Krynetski EY, Krynetskaia NF, Gallo AE, Murti KG, Evans WE. 2001. A novel protein complex distinct from mismatch repair binds thioguanylated DNA. Mol Pharm 59:367-374.
29. Krynetski EY, Krynetskaia NF, Bianchi ME, Evans WE. 2003. A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues. Cancer Res 63:100-106.
30. Li B, Oestriech S, de Lange T. 2000. Identification of human Rap1: Implications for telomere evolution. Cell 101:471-483.
31. Lu S, Gu X, Hoestje S, Epner DE. 2002. Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochim Biophys Acta 1574:152-156.
32. Luo Y, Roeder RG. 1995. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol Cell Biol 15: 4115-4124.
33. McKnight S. 2003. Gene switching by metabolic enzymes- How did you get on the invitation list? Cell 114: 150-152.
34. Mounkes LC, Kozlov S, Hernandez L, Sullivan T, Steward CL. 2003. A progeroid syndrome in mice is caused by defects in A type lamins. Nature 423:298-301.
35. Nakagawa T, Hirano Y, Inomata A, Yokota S, Miyachi K, Kaneda M, Umeda M, Furukawa K, Omata S, Horigome T. 2003. Participation of a fusogenic protein, glyceraldehyde-3-phosphate dehydrogenase, in nuclear membrane assembly. J Biol Chem 278:20395-20404.
36. Nathan D. 1994. Relationship between metabolic control and long term complications of diabetes. In: Kahn CR, Weir G, editors. Joslin's diabetes. Philadelphia, PA: Lea and Febiger; 620-631.
37. Neidle S, Parkinson GN. 2003. The structure of telomeric DNA. Curr Opin Struct Biol 13:275-283.
38. Nishikawa T, Edelstein D, Du XL, Yamagishi S-I, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Gates PJ, Hammes H-P, Giardino I, Brownlee M. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790.
39. Ogretmen B, Schady D, Usta J, Wood R, Kraveka JM, Luberto C, Birbes H, Hannun YA, Obeid LM. 2001. Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells. J Biol Chem 276:24901-24910.
40. Reaven GM. 1995. Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473-486.
41. Reiss N, Kanety H, Schlessinger J. 1986. Five enzymes of the glycolytic pathway serve as substrates for purified epidermal-growth-factor-receptor kinase. Biochem J 239: 691-697.
42. Reusch JEB. 2003. Diabetes, microvascular complications, and cardiovascular complications: What is it about glucose? J Clin Invest 112:986-988.
43. Robbins AR, Ward RD, Oliver C. 1995. A mutation in glyceraldehyde-3- phosphate dehydrogenase alters endocytosis in CHO cells. J Cell Biol 130:1093-1104.
44. Saunders PA, Chen R-W, Chuang D-M. 1999. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J Neurochem 72:925-932.
45. Scaglione R, Argano C, Di Chiara T, Licata G. 2004. Obesity and cardiovascular risk: The new public health problem of worldwide proportions. Exp Rev Cardiovas Ther 2:203-212.
46. Schmitz H-D. 2001. Reversible nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase upon serum stimulation. Eur J Cell Biol 80:419-427.
47. Shinohara M, Thornalley PJ, Giardino I, Beisswenger P, Thorpe SR, Onorato J, Brownlee M. 1998. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101:1142-1147.
48. Sirover MA. 1999. New insight into an old protein: The functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432: 159-184.
49. Sundararaj KP, Wood RE, Ponnusamy S, Salas AM, Szule Z, Bielawska A, Obeid LM, Hannun YA, Ogretmen B. 2004. Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 279:6152.
50. Tajima H, Tsuchiya K, Yamada M, Kondo K, Katsube N, Ishitani R. 1999. Over-expression of GAPDH induces apoptosis in COS-7 cells transfected with cloned GAPDH cDNAs. Neuro Report 10:2029-2033.
51. Tisdale EJ. 2001. Glyceraldehyde-3-phosphate dehydrogenase is required for vesicular transport in the early secretory pathway. J Biol Chem 276:2480-2486.
52. Tisdale EJ. 2002. Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by protein kinase Cι/λ and plays a role in microtubule dynamics in the early secretory pathway. J Biol Chem 277:3334-3341.
53. Tisdale EJ. 2003. Rab2 interacts directly with atypical protein kinase C (aPKC) ι/λ and inhibits aPKC ι/λ-dependent glyceraldehyde-3-phosphate dehydrogenase phosphorylation. J Biol Chem 278:52524-52530.
54. Tsuchiya K, Tajima H, Yamada M, Takahashi H, Kuwae T, Sunaga K, Katsube N, Ishitani R. 2004. Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: Anti-dementia drugs depress its activation in apoptosis. Life Sci 74:3245-3258.
55. Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee KH, Harrison DG, Tsaw PS. 2001. Diabetes mellitus enhances vascular metalloproteinase activity: Role of oxidative stress. Cir Res 88:1291-1298.
56. Wang J, Shiels C, Sasieni P, Wu PJ, Islam SA, Freemont PS, Sheer D. 2004. Promyelocytic leukemia bodies associate with transcriptionally active genomic regions. J Cell Biol 164:515-526.
57. Zheng L, Roeder RG, Luo Y. 2003. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 114: 255-266.